Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?

MLA

Flores, Jose M., et al. “Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?” Journal of Urology, vol. 211, no. 3, Mar. 2024, pp. 401–06. EBSCOhost, https://doi.org/10.1097/JU.0000000000003823.

APA

Flores, J. M., Vertosick, E., Jenkins, L. C., Cooper, J., Benfante, N., Sjoberg, D., Vickers, A. J., Eastham, J. A., Laudone, V. P., Scardino, P. T., Nelson, C. J., Mulhall, J. P., Holland, L. C., & Taylor, J. (2024). Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy? Journal of Urology, 211(3), 401–406. https://doi.org/10.1097/JU.0000000000003823

Chicago

Flores, Jose M., Emily Vertosick, Lawrence C. Jenkins, John Cooper, Nicole Benfante, Daniel Sjoberg, Andrew J. Vickers, et al. 2024. “Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?” Journal of Urology 211 (3): 401–6. doi:10.1097/JU.0000000000003823.